Phaware Global Association

Pulmonary hypertension (PH) is a rare, life-threatening disease affecting the arteries of the lungs that can lead to right heart failure. Pulmonary hypertension (PH) is a rare, chronic illness of the lungs that affects the functioning of the heart and can lead to right heart failure. While there’s currently no cure, there are 16 FDA-approved therapies available to help patients live better lives.

07/13/2026

The Early Days: The Origins of PH Therapies and Trials LIVE Zoom Webinar
WED Jul 22 1PM PT | 4PM ET
Sharon I. S. Rounds, MD, ATSF shares a powerful historical perspective on the early days of PH, reflecting on a time when clinicians faced devastating diagnoses with little more than compassion and hope. Discover how those early experiences helped shape decades of innovation, advocacy, and life-changing advances in PAH treatment. REGISTER NOW: https://www.phaware.global/webinars

07/06/2026

Join us all summer long for a LIVE On Air with phaware® Zoom Webinar Series as we explore the remarkable evolution of Pulmonary Arterial Hypertension (PAH)—from its earliest challenges to today's breakthroughs and the promising future of research and care. Whether you're a patient, caregiver, healthcare professional, researcher, or advocate, these live conversations will offer valuable insight into how far the PH community has come—and where it's headed next. Register Now for our first Webinar: The Early Days of PH: Consensus On The Target. WED JULY 22 1pm PT | 4pm ET Register now: https://www.phaware.global/webinars

07/02/2026

THIS JULY ON THE Phaware Global Association PODCAST. Four Powerful PH Stories. Four Unforgettable Journeys. One Community That Never Stops Fighting. Like | Follow | Subscribe: https://phawarepodcast.libsyn.com/site